• RIN3-BIN1 Disruption Drives RAB5 Hyperactivation in Alzheime

  2026-05-30

  This study uncovers how mutations in RIN3 disrupting its interaction with BIN1 lead to RAB5 hyperactivation and endosomal abnormalities, key features of early Alzheimer’s disease (AD) pathology. The work clarifies the mechanistic link between two major AD risk genes and highlights the importance of endosomal trafficking in disease initiation.

• Redefining mRNA Tracking: Dual-Reporter Tools Meet Advanced

  2026-05-29

  This thought-leadership article examines the transformative role of dual-reporter mRNA systems—specifically EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP)—in overcoming translational research bottlenecks in delivery, imaging, and immunogenicity. Leveraging mechanistic advances in mRNA engineering and referencing recent breakthroughs in virus-mimicking nanocarriers, we offer strategic guidance for researchers striving for reliable, immune-silent, and multiplexed mRNA assays. The discussion bridges recent literature with practical workflow recommendations, and positions APExBIO’s platform as a key enabler for reproducible, high-impact mRNA research.

• Tunable Human Intestinal Organoids: Balancing Self-Renewal a

  2026-05-29

  This study introduces a tunable human intestinal organoid system that achieves a controlled balance between stem cell self-renewal and differentiation, enabling both high proliferative capacity and cellular diversity under a single culture condition. These advances support scalable, high-throughput research and address key limitations of previous organoid models.

• ALDOB K87 Lactylation Drives Mitochondrial Fission in PH

  2026-05-28

  This study identifies ALDOB K87 lactylation as a critical regulator of mitochondrial fission and metabolic reprogramming in pulmonary hypertension (PH). By dissecting the lactate–ALDOB–DRP1 signaling axis, the research offers significant mechanistic insight into pulmonary vascular remodeling and highlights new avenues for targeted intervention.

• Lung-Targeted Risedronate Sodium Delivery Improves Osteoporo

  2026-05-28

  This study introduces a lung-targeted nano-delivery system for Risedronate Sodium and vitamin D₃ using PAMAM-G5 dendrimers, dramatically enhancing bioavailability and therapeutic efficacy in osteoporosis models. The approach surmounts oral delivery limitations and provides new insights into bone metabolism regulation, with implications for translational bone research.

• Atorvastatin in Cellular Ferroptosis: New Paradigms in HMG-C

  2026-05-27

  Explore how Atorvastatin, a leading HMG-CoA reductase inhibitor, is advancing cholesterol metabolism research and pioneering ferroptosis-based strategies in hepatocellular carcinoma and vascular biology. This article delivers a unique, mechanistic perspective for researchers seeking deeper insights.

• Optimizing Protein Labeling with Cy5 Maleimide (Non-sulfonat

  2026-05-27

  This article addresses common laboratory challenges in fluorescent protein labeling and assay reproducibility, focusing on the application of Cy5 maleimide (non-sulfonated, SKU A8139). Scenario-driven Q&As provide actionable insights and evidence-based recommendations for achieving reliable, site-specific cysteine labeling in cell viability and imaging experiments.

• Dual-Action Kinase Inhibitors Accelerate p38α MAPK Dephospho

  2026-05-26

  The reference study uncovers that certain kinase inhibitors not only block p38α MAPK activity but also promote its dephosphorylation by favoring conformations accessible to phosphatases. This dual-action mechanism offers new possibilities for designing highly specific inhibitors relevant to inflammation and apoptosis research.

• Imeglimin Enhances Mitochondrial Function in CTS-Associated

  2026-05-26

  This study demonstrates that Imeglimin significantly improves mitochondrial function and reduces cell stress in subsynovial connective tissue (SSCT) cells from idiopathic carpal tunnel syndrome (CTS) patients. The findings highlight Imeglimin's potential as a targeted intervention for mitochondrial dysfunction in connective tissue fibrosis.

• 4-Ethylphenyl Sulfate in Gut-Brain and Renal Dysfunction Mod

  2026-05-25

  4-Ethylphenyl sulfate empowers advanced modeling of gut microbiota-brain interactions and serves as a robust biomarker tool in renal dysfunction research. Leveraging its high solubility and purity, APExBIO’s 4-ethylphenyl hydrogen sulfate streamlines protocols for behavioral, biochemical, and surface adsorption studies.

• Translating mRNA Innovation: Mechanisms and Strategy with EZ

  2026-05-25

  This thought-leadership article explores the advanced mechanistic features and strategic applications of EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP), offering translational researchers a roadmap for optimizing mRNA delivery, expression, and dual-modality imaging. Drawing on recent reference findings and industry trends, we contextualize how this next-generation reporter system redefines standards in workflow design, immune evasion, and data quantification, while providing actionable protocol guidance and a forward-looking outlook.

• Sulfo-Cy3 NHS Ester: Transforming Capillary Remodeling Studi

  2026-05-24

  Sulfo-Cy3 NHS Ester offers a mechanistically robust and workflow-optimized solution for fluorescent labeling of amino groups, empowering translational researchers to interrogate complex vascular remodeling processes such as those mediated by the AIBP-LRP2–HDL–CXCR4 axis. This article bridges recent mechanistic insights from high-impact studies with actionable protocol guidance and competitive analysis, providing a visionary outlook for translational vascular biology.

• EZ Cap Cy5 Firefly Luciferase mRNA: Precision Tracking & Ass

  2026-05-23

  Explore the advanced features of EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP), a dual-reporter for precise mRNA delivery and intracellular tracking. Learn how its unique modifications enable robust translation efficiency, immune evasion, and optimized assay workflows.

• Triptolide Disrupts Genome Integrity via DNA-PKcs Inhibition

  2026-05-22

  This study demonstrates that triptolide directly impairs genome integrity in human cells by inhibiting the enzymatic activity of DNA-PKcs, a key kinase in non-homologous end joining (NHEJ) DNA repair. The findings provide mechanistic insight into triptolide's genotoxicity and inform the design of DNA damage assays and cancer research workflows.

• Risedronate Sodium: Optimized Workflows in Bone & Cancer Res

  2026-05-22

  Risedronate Sodium, a potent FPP synthase inhibitor from APExBIO, enables high-impact bone metabolism and cancer research through robust, reproducible protocols and advanced delivery strategies. Discover workflow enhancements, troubleshooting insights, and translational applications backed by rigorous clinical and experimental evidence.

15899 records 1/1060 page Next 12345 下5页 Last page